A compound according to Formula I: wherein R 1 is H, or Me; L 1 is -NR 2 -; -O-, or -CH 2 -; Cy is phenyl, or 5-9 membered monocyclic or fused bicyclic heteroaryl comprising 1 to 4 heteroatoms independently selected from N, O, and S; R 2 is H, or C 1-4 alkyl; R 3 is H, halo, C 1-4 alkyl optionally substituted with one or more halo, or C 1-4 alkoxy optionally substituted with one or more halo; R 4 is H, or halo; R 5 is -CN, halo, or is -L 2 -R 6; -L 2 is absent, or is -C(=O)-, -C(=O)NR 7 -, -NR 7 C(=O)-, -SO 2 -, -SO 2 NR 7 -, or -NR 7 SO 2 -; R 6 is H, or C 1-6 alkyl optionally substituted with one or more independently selected R 8 groups; R 7 is H, or C 1-4 alkyl; R 8 is OH, CN, halo, or C 1-4 alkoxy, L a is absent, or is -C(=O)-, -C(=O)O-, or -C(=O)NH-; R a is: - H, - C 1-4 alkyl optionally substituted with one or more independently selected R b, - C 3-7 monocyclic cycloalkyl optionally substituted with one or more independently selected R c, or - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S, or - 5-6 membered monocyclic heteroaryl comprising one or more heteroatoms independently selected from O, N, and S; R b is - halo, - CN, - OH, - C 1-4 alkoxy, - C 3-7 cycloalkyl, - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S (which heterocycloalkyl is optionally substituted with one or more independently selected halo, or oxo) - -SO 2 -C 1-4 alkyl, or - -C(=O)NR b1 R b2 R c is - halo, - CN, - OH, - C 1-4 alkyl, - -C(=O)OH, or - -C(=O)NR c1 R c2; and each R b1, R b2, R c1 and R c2 is independently selected from H, and C 1-4 alkyl, or a pharmaceutically acceptable salt, or a solvate, or a solvate of the pharmaceutically acceptable salt. R 1 is H, or Me; L 1 is -NR 2 -; -O-, or -CH 2 -; Cy is phenyl, or 5-9 membered monocyclic or fused bicyclic heteroaryl comprising 1 to 4 heteroatoms independently selected from N, O, and S; R 2 is H, or C 1-4 alkyl; R 3 is H, halo, C 1-4 alkyl optionally substituted with one or more halo, or C 1-4 alkoxy optionally substituted with one or more halo; R 4 is H, or halo; R 5 is -CN, halo, or is -L 2 -R 6; -L 2 is absent, or is -C(=O)-, -C(=O)NR 7 -, -NR 7 C(=O)-, -SO 2 -, -SO 2 NR 7 -, or -NR 7 SO 2 -; R 6 is H, or C 1-6 alkyl optionally substituted with one or more independently selected R 8 groups; R 7 is H, or C 1-4 alkyl; R 8 is OH, CN, halo, or C 1-4 alkoxy, L a is absent, or is -C(=O)-, -C(=O)O-, or -C(=O)NH-; R a is: - H, - C 1-4 alkyl optionally substituted with one or more independently selected R b, - C 3-7 monocyclic cycloalkyl optionally substituted with one or more independently selected R c, or - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S, or - 5-6 membered monocyclic heteroaryl comprising one or more heteroatoms independently selected from O, N, and S; - H, - C 1-4 alkyl optionally substituted with one or more independently selected R b, - C 3-7 monocyclic cycloalkyl optionally substituted with one or more independently selected R c, or - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S, or - 5-6 membered monocyclic heteroaryl comprising one or more heteroatoms independently selected from O, N, and S; R b is - halo, - CN, - OH, - C 1-4 alkoxy, - C 3-7 cycloalkyl, - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S (which heterocycloalkyl is optionally substituted with one or more independently selected halo, or oxo) - -SO 2 -C 1-4 alkyl, or - -C(=O)NR b1 R b2 - halo, - CN, - OH, - C 1-4 alkoxy, - C 3-7 cycloalkyl, - 4-7 membered monocyclic heterocycloalkyl comprising one or more heteroatoms independently selected from O, N, and S (which heterocycloalkyl is optionally substituted with one or more independently selected halo, or oxo) - -SO 2 -C 1-4 alkyl, or - -C(=O)NR b1 R b2 R c is - halo, - CN, - OH, - C 1-4 alkyl, - -C(=O)OH, or - -C(=O)NR c1 R c2; and - halo, - CN, - OH, - C 1-4 alkyl, - -C(=O)OH, or - -C(=O)NR c1 R c2; and each R b1, R b2, R c1 and R c2 is independently selected from H, and C 1-4 alkyl, or a pharmaceutically acceptable salt, or a solvate, or a solvate of the pharmaceutically acceptable salt.